| UNEP/POPS/POPRC.4/1 | Provisional agenda |   |
| UNEP/POPS/POPRC.4/1/Add.1 | Annotated agenda | |
| UNEP/POPS/POPRC.4/2 | Forthcoming rotation of the membership |  |
| UNEP/POPS/POPRC.4/3 | Preventing and dealing with conflicts of interest on the part of members of the Persistent Organic Pollutants Review Committee | |
| UNEP/POPS/POPRC.4/4 | Summary of the activities undertaken for effective participation in the work of the Committee | |
| UNEP/POPS/POPRC.4/5 | Draft workplans for the period between the fourth and fifth meetings of the Committee | |
| UNEP/POPS/POPRC.4/6 | Draft risk management evaluation: octabromodiphenyl ether | |
| UNEP/POPS/POPRC.4/7 | Draft risk management evaluation: pentachlorobenzene | |
| UNEP/POPS/POPRC.4/8 | Draft risk management evaluation: alpha hexachlorocyclohexane | |
| UNEP/POPS/POPRC.4/9 | Draft risk management evaluation: beta hexachlorocyclohexane | |
| UNEP/POPS/POPRC.4/10 | Updated draft risk profile: short-chained chlorinated paraffins | |
| UNEP/POPS/POPRC.4/11 | Summary of the proposal for the listing of hexabromocyclododecane (HBCDD) in Annex A to the Convention | |
| UNEP/POPS/POPRC.4/12 | Format of the recommendations of the Committee on the listing of chemicals to the Conference of the Parties | |
| UNEP/POPS/POPRC.4/13 | Summary of information on unintentional releases of pentachlorobenzene | |
| UNEP/POPS/POPRC.4/14 | Endosulfan proposal | |
| UNEP/POPS/POPRC.4/15 | Report of the Persistent Organic Pollutants Review Committee on the work of its fourth meeting | |
| UNEP/POPS/POPRC.4/15/Add.1 | Risk management evaluation for commercial octabromodiphenyl ether | |
| UNEP/POPS/POPRC.4/15/Add.2 | Risk management evaluation for pentachlorobenzene | |
| UNEP/POPS/POPRC.4/15/Add.3 | Risk management evaluation for alpha hexachlorocyclohexane | |
| UNEP/POPS/POPRC.4/15/Add.4 | Risk management evaluation for beta hexachlorocyclohexane | |
| UNEP/POPS/POPRC.4/15/Add.5 | Addendum to the risk profile for pentachlorobenzene | |
| UNEP/POPS/POPRC.4/15/Add.6 | Addendum to the risk management evaluation for perfluorooctane sulfonate | |